Nimodipine

Serious Harm with IV Administration of Oral Product

  • Do not administer Nimotop intravenously or by by other parenteral routes. Deaths and serious, life-threatening adverse events have occurred when the contents of Nimotop capsules have been injected parenterally. (see WARNINGS and DOSAGE AND ADMINISTRATION).

Communications

Package inserts

Additional information

Keywords: Nimotpo
Updated: January 2018